You are here: Industry Insights > Market News > Yemen to get more COVID-19 vaccines by end of month - health ministry

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Brexpiprazole Intermediate CAS:913613-82-8

Erythorbic Acid (Molecular Formula:C₆H₈O₆)

Sodium Erythorbate(Molecular Formula:C₆H₇NaO₆·H₂O)

water filter

WATER FILTER FOR WATER PURIFIER

DUST BAG

Yemen to get more COVID-19 vaccines by end of month - health ministry

firstwordpharmaJuly 19, 2021

Tag: COVID-19 , vaccines , Covax

Favorites

Yemen expects to get a second batch of COVID-19 vaccine by the end of this month through the COVAX global vaccine-sharing scheme, as reported National Post on Sunday.

Yemen to get more COVID-19 vaccines by end of month - health ministry

The health ministry said that Yemen is expecting to receive 151,000 doses of the Johnson & Johnson vaccine, out of an eventual total of 504,000, while another batch of AstraZeneca's vaccine doses is expected via COVAX in August.

Previous:To Combat COVID-19 Vaccine Hesitancy in Black Community, Twin Sister Doctors Develop Strategy

Next:British ministers decide against mass vaccination for teens - The Telegraph

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Yemen to get more COVID-19 vaccines by end of month - health ministry | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

Yemen to get more COVID-19 vaccines by end of month - health ministry

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may like
More>>

Yemen to get more COVID-19 vaccines by end of month - health ministry

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>